Swiftmerge Acquisition Price to Free Cash Flow Ratio 1970-1969 | ANNA

Historical price to free cash flow ratio values for Swiftmerge Acquisition (ANNA) since 1970. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Swiftmerge Acquisition Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-12-20 7.19 inf
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.042B $0.000B
Swiftmerge Acquisition Corp. entered into definitive merger agreement with HDL Therapeutics Inc.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
Pieris Pharmaceuticals (PVLA) United States $0.016B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00